α-Synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models

AA Cooper, AD Gitler, A Cashikar, CM Haynes, KJ Hill… - Science, 2006 - science.org
AA Cooper, AD Gitler, A Cashikar, CM Haynes, KJ Hill, B Bhullar, K Liu, K Xu, KE Strathearn…
Science, 2006science.org
Alpha-synuclein (αSyn) misfolding is associated with several devastating
neurodegenerative disorders, including Parkinson's disease (PD). In yeast cells and in
neurons αSyn accumulation is cytotoxic, but little is known about its normal function or
pathobiology. The earliest defect following αSyn expression in yeast was a block in
endoplasmic reticulum (ER)–to–Golgi vesicular trafficking. In a genomewide screen, the
largest class of toxicity modifiers were proteins functioning at this same step, including the …
Alpha-synuclein (αSyn) misfolding is associated with several devastating neurodegenerative disorders, including Parkinson's disease (PD). In yeast cells and in neurons αSyn accumulation is cytotoxic, but little is known about its normal function or pathobiology. The earliest defect following αSyn expression in yeast was a block in endoplasmic reticulum (ER)–to–Golgi vesicular trafficking. In a genomewide screen, the largest class of toxicity modifiers were proteins functioning at this same step, including the Rab guanosine triphosphatase Ypt1p, which associated with cytoplasmic αSyn inclusions. Elevated expression of Rab1, the mammalian YPT1 homolog, protected against αSyn-induced dopaminergic neuron loss in animal models of PD. Thus, synucleinopathies may result from disruptions in basic cellular functions that interface with the unique biology of particular neurons to make them especially vulnerable.
AAAS